🧬 Non-Hodgkin’s Lymphoma (NHL)

📌 Definition

Non-Hodgkin’s Lymphoma is a diverse group of blood cancers originating in lymphocytes, characterized by the absence of Reed-Sternberg cells and often presenting with widespread lymph node involvement.

🧠 Anatomy & Physiology: Lymphatic System

  • Lymphocytes: B and T cells central to immune response
  • Lymph nodes: Primary site of tumor development
  • Other sites: Spleen, thymus, tonsils, GI tract, skin, CNS
  • Widespread: May involve multiple organ systems at diagnosis

⚠️ Etiology: Causes & Risk Factors

  • Immunosuppression (e.g., post-transplant, HIV)
  • Infections: EBV, H. pylori, Hepatitis C
  • Autoimmune diseases (e.g., SLE, Sjögren’s)
  • Exposure to chemicals (herbicides, pesticides)
  • Older age, male sex

🩺 Symptomatology

  • Painless, enlarged lymph nodes (neck, axilla, groin)
  • Fever, night sweats, weight loss (B symptoms)
  • Abdominal fullness, early satiety (splenomegaly)
  • Chest pain, cough (mediastinal mass)
  • Fatigue, anemia, infections (bone marrow involvement)

🔁 Pathophysiology (Simplified)

  1. Genetic or environmental trigger → mutation in lymphocyte DNA
  2. Uncontrolled proliferation of B or T cells
  3. Infiltration of lymphatic & extranodal tissue
  4. Immune dysfunction → increased infection risk

🧪 Medical Management

🔬 Labs & Diagnostics

  • Lymph node biopsy – confirms NHL, classifies subtype
  • PET/CT scan – evaluates spread/staging
  • Bone marrow biopsy – detects infiltration
  • LDH – marker of tumor burden

💊 Medications

  • CHOP regimen: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone
  • Rituximab – monoclonal antibody for B-cell NHL
  • Targeted and immunotherapies for aggressive or refractory types

🛠️ Treatments

  • Chemotherapy – mainstay for most subtypes
  • Radiation – for localized disease
  • Stem cell transplant – for relapsed/resistant NHL
  • CAR T-cell therapy – for specific aggressive forms

🧑‍⚕️ Nursing Management: 5 Key Interventions

  1. Monitor for neutropenia and prevent infection
  2. Manage chemo side effects (e.g., nausea, mucositis)
  3. Promote energy conservation and adequate nutrition
  4. Provide emotional and psychosocial support
  5. Educate on signs of relapse and follow-up care

🩹 Priority Nursing Diagnoses

  • Risk for infection related to immunosuppression
  • Imbalanced nutrition: Less than body requirements
  • Fatigue related to disease and treatment
  • Disturbed body image
  • Anxiety related to diagnosis and prognosis

📉 Prognosis

  • Indolent type: Slow progression, median survival 10+ years
  • Aggressive type: Curable with treatment, 60–80% remission
  • Refractory type: Requires advanced therapies (CAR T, SCT)

Note: Prognosis depends on subtype, stage, and response to treatment.